Work

Effect of Ofatumumab on Serum Immunoglobulin Levels and Infection Risk in Relapsing Multiple Sclerosis (RMS) Patients from the Phase 3 ASCLEPIOS I and II Trials (1300)

Year: 2021

Type: article

Source: Neurology

DOI: 10.1212/wnl.96.15_supplement.1300

Authors: Amit Bar-Or, Jerome De Seze, Jorge Correale, Anne Cross, Ludwig Kappos, Krzysztof Selmaj, Heinz Wiendl, Cecile Kerloeguen, Ratnakar Pingili, Roseanne Sullivan, Ayan Das Gupta, Valentine Jehl, Dieter Haering, Martin Merschhemke, Stephen Hauser

Institutions: University of Pennsylvania, Hôpitaux Universitaires de Strasbourg, Washington University in St. Louis, University of Basel, University of Münster, Novartis (Switzerland), Novartis (United States), University of California, San Francisco

Language: English

Topic: Multiple Sclerosis Research Studies

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3207771670

FWCI: 1.639

Cites:

Cited by: 11

Related to: 10